Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office

MRI Detection of Carotid Plaques as a mechanism for embolic strokes of undetermined source (MRI DECIPHER)

Clinical Trial Details

The study is investigating a link between high-risk plaque and cardioembolic sources among patients with stroke of unknown causes. This observational study uses an MRI protocol to detect bleeds within plaque, a marker of high-risk plaque. There is an additional PET/MRI that patients can opt into to more closely observe the plaque within the carotid arteries.

This study includes optional parts which will have financial compensation.

Key Eligibility: 
  • Men and women 18 years or older with a diagnosis of ischemic stroke
  • The stroke must be classified as "cryptogenic" or with no known cause
  • Ability to participate in MRI scans
  • Cannot be pregnant or breastfeeding
  • Detailed eligibility will be reviewed when you contact the study team.
Return to List

Study contact by location

Upper East Side - Manhattan

Contact(s)

Carla Sherman
(646) 962-8284
cas9149@med.cornell.edu

Primary Investigator(s)

Hooman Kamel, MD

Protocol ID(s)

Weill Cornell Medicine IRB #:

1904020152

Status

Open to Enrollment

Age Group

Adult

Sponsor

  • National Institutes of Health (NIH)

Disease

Intracranial Hemorrhage
Stroke